Selective α-Synuclein Knockdown in Monoamine Neurons by Intranasal Oligonucleotide Delivery: Potential Therapy for Parkinson’s Disease

類似資料

• Anti-α-synuclein ASO delivered to monoamine neurons prevents α-synuclein accumulation in a Parkinson's disease-like mouse model and in monkeys
  著者:: Alarcón-Arís, Diana, 等
  出版事項: (2020)
• Intracerebral Administration of a Ligand-ASO Conjugate Selectively Reduces α-Synuclein Accumulation in Monoamine Neurons of Double Mutant Human A30P*A53T*α-Synuclein Transgenic Mice
  著者:: Pavia-Collado, Rubén, 等
  出版事項: (2021)
• Intracellular crowding by age-dependent neuromelanin accumulation disrupts neuronal proteostasis and triggers Parkinson disease pathology
  著者:: Vila, Miquel, 等
  出版事項: (2019)
• Therapeutic antidepressant potential of a conjugated siRNA silencing the serotonin transporter after intranasal administration
  著者:: Ferrés-Coy, A, 等
  出版事項: (2016)
• Lack of pathogenic potential of peripheral α-synuclein aggregates from Parkinson’s disease patients
  著者:: Ariadna Recasens, 等
  出版事項: (2018-02-01)